Updated CERAMENT BONE VOID FILLER (BVF) instructions for use for the US market
Lund, Sweden, 15:00 CET, 19 October 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announces that the company, through a 510 (k) to the Food and Drug Administration (FDA), has updated its CERAMENT® BONE VOID FILLER (BVF) instructions for use for the US market. The update includes clarification of the indication bone cysts and tumors to include adults and children above the age of nine. For more information contact: BONESUPPORT ABEmil Billbäck, CEO+46 (0) 46 286 53 70 Håkan Johansson, CFO+46 (0) 46 286 53 70ir@bonesupport.com